update

NYSE CONTENT ADVISORY: TODAY’S PRE-MARKET UPDATE

NEW YORK, Dec. 17, 2024 /PRNewswire/ -- The New York Stock Exchange (NYSE) is proud to offer a new daily pre-market…

5 months ago
NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024

NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024

Exclusive Market Insights Recorded Daily from the NYSE Trading Floor NEW YORK, Dec. 16, 2024 /PRNewswire/ -- The New York…

5 months ago
NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024

NEW YORK STOCK EXCHANGE PRE-MARKET UPDATE DECEMBER 16, 2024

Exclusive Market Insights Recorded Daily from the NYSE Trading Floor NEW YORK, Dec. 16, 2024 /PRNewswire/ -- The New York…

5 months ago
Nova Leap Health Corp. provides update on Special MeetingNova Leap Health Corp. provides update on Special Meeting

Nova Leap Health Corp. provides update on Special Meeting

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Dec. 13, 2024…

5 months ago
LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in ChinaLakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China

December 12, 2024 19:57 ET | Source: LakeShore Biopharma Co., Ltd BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma…

5 months ago
Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on MitapivatAgios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivatat ASH 2024 and Provides Regulatory Update on Mitapivat

– ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia – –…

5 months ago
Fobi AI Provides Update on Current Cease Trade OrderFobi AI Provides Update on Current Cease Trade Order

Fobi AI Provides Update on Current Cease Trade Order

December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British Columbia, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Fobi…

5 months ago
Fobi AI Provides Update on Current Cease Trade OrderFobi AI Provides Update on Current Cease Trade Order

Fobi AI Provides Update on Current Cease Trade Order

December 06, 2024 20:34 ET | Source: Fobi AI Inc. VANCOUVER, British Columbia, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Fobi…

5 months ago
BitFuFu Announces November 2024 Production and Mining Operations UpdateBitFuFu Announces November 2024 Production and Mining Operations Update

BitFuFu Announces November 2024 Production and Mining Operations Update

December 06, 2024 06:00 ET | Source: BitFuFu Inc. ● 1,643 BTC held and 84 BTC produced from self-mining operations…

5 months ago
MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MNDMediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

MediciNova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS (COMBAT-ALS Clinical Trial) at the 35th International Symposium on ALS/MND

December 05, 2024 18:00 ET | Source: MediciNova, Inc. LA JOLLA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- MediciNova, Inc.,…

5 months ago